NDA study for Mexico [Regulatives / Guidelines]

posted by jag009  – NJ, 2019-12-06 17:19 (1094 d 22:00 ago) – Posting: # 20943
Views: 2,936

Hi,

Does anyone have experience conducting NDA studies for ER products in Mexico? I mean running a study comparing ER once a day vs IR given multi-times a days, e.g, ER vs IR given every 4 hours. When conducting such studies, the success criteria is based on equivalent AUC (90% CI), and not Cmax due to the nature of the ER drug release kinetic.

I received a comment from the mexico regulatory when they reviewed the protocol. They wanted Cmax as an equivalent criteria as well but that is not my intention (I ran studies like this in US and usually this is not a problem at the protocol review stage).


Thx
J

Complete thread:

UA Flag
Activity
 Admin contact
22,428 posts in 4,694 threads, 1,598 registered users;
14 visitors (0 registered, 14 guests [including 6 identified bots]).
Forum time: 15:19 CET (Europe/Vienna)

Statistics is the art of never having to say you’re wrong.
Variance is what any two statisticians are at.    C.J. Bradfield

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5